TORONTO, Nov. 11, 2024 /PRNewswire/ – MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its […]
Company Now Materially Debt Free with Over $13M in Cash TORONTO, Sept. 17, 2024 /PRNewswire/ – MediPharm Labs Corp. (“MediPharm” or the “Company”) (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health products, is […]
TORONTO, Aug. 8, 2024 /PRNewswire/ – MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its […]
